During the past decade, Fundatia Dr. Victor Babes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundatia Dr. Victor Babes" are "Hepatitis Delta Virus" (2 trials), "COPD" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Fundatia Dr. Victor Babes" in a lesser frequency.

Most popular intervention types in "Fundatia Dr. Victor Babes" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Astegolimab" (1 trials), "Lonafarnib" (1 trials), "PEG IFN-alfa-2a" (1 trials) and "Peginterferon Lambda-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundatia Dr. Victor Babes" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fundatia Dr. Victor Babes". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fundatia Dr. Victor Babes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundatia Dr. Victor Babes, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".